Canadian Manufacturer Warned for Adulterated APIs

International Pharmaceutical Regulatory Monitor
A A
The FDA warned Montreal, Quebec-based drugmaker Les Produits Chimiques that serious quality unit failures caused its APIs to be adulterated.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00